# Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

> **NCT00396721** · PHASE2 · COMPLETED · sponsor: **Josep m Cruzado** · enrollment: 23 (actual)

## Conditions studied

- Glomerulonephritis, IGA
- Nephropathy, IGA
- IGA Nephropathy

## Interventions

- **DRUG:** ACE inhibitor + statin
- **DRUG:** Sirolimus (study drug)+ACE inhibitor + statin

## Key facts

- **NCT ID:** NCT00396721
- **Lead sponsor:** Josep m Cruzado
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-10
- **Final completion:** 2010-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2011-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396721, "Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00396721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*